BRD2 and ovarian hyperstimulation syndrome: Ovarian reserve marker-based individualized follicle stimulating hormone (FSH) dosing in women with predicted hyper responders (AFC > 15) undergoing ART can reduce the occurrence of ovarian hyperstimulation syndrome (OHSS).